Join A&M Healthcare Industry Group's Marthe Haverkamp, M.D., Ph.D, as she sits down with world-renowned virologist Ab Osterhaus, Ph.D., and vaccine expert Manon Cox, Ph.D., MBA, Chief Executive Officer and Co-Founder of NextWaveBio. They discuss the future of vaccines, the value of COVID-19 treatments, and the influence of Omicron on the pandemic: Is a relatively mild disease now a comparative advantage for the future?
https://www.alvarezandmarsal.com/insights/is-omicron-our-way-out
In this episode of the "What's Your Moonshot?" podcast, Dr. Bruce Meyer, Executive Vice President and Chief Population Health Officer at Highmark Health, shares...
Earlier this year, CMS finalized multiple rules that impact MAOs, with significant ramifications to procedures for RADV audits. Listen as A&M Healthcare Industry Group...
Tiffany Nugent, Vice President of People Operations at Olive joins A&M’s Bianca A. Briola for Episode 3 of The Future of Healthcare Human Capital...
